Nurhan ŞAHİN, Cemal ORHAN, Zeynep TUZCU, Kazim ŞAHİN, James R. KOMOROWSKI

Combined oral supplementation of chromium picolinate, docosahexaenoic acid, and boron enhances neuroprotection in rats fed a high-fat diet

Background/aim: A novel complex of a nutritional supplement (CDB) contains chromium picolinate (CrPic), phosphatidylserine (PS), docosahexaenoic acid (DHA), and boron (B). The present study aimed to investigate the effects of CDB on the metabolic profile and memory acquisition in rats fed a high-fat diet (HFD). Materials and methods: Male Wistar rats were divided into six groups and received either a regular diet or HFD supplemented with or without different levels of CDB (0, 11, or 22 mg/kg BW). Results: Rats fed the HFD had greater glucose, insulin, lipid profile, and serum malondialdehyde concentrations, but lower serotonin and tryptophan in the serum and brain and lower Cr concentrations in serum, kidney, brain, and liver (P < 0.0001). CDB complex supplementation reversed all the effects, and the reversal effect was more pronounced with HFD for some parameters. Latency was less (P < 0.05) but probe was greater (P < 0.0001) for rats fed a regular diet. Increasing CDB complex levels in the diets resulted in a linear decrease in latency (P < 0.0002) but a linear increase in probe (P < 0.0002). Conclusion: Findings of the present work indicate that the CDB complex could be considered as an alternative treatment for preventing certain metabolic diseases and improving neurological functions, such as learning and memory.

PDF

___

1. Alzoubi KH, Abdul-Razzak KK, Khabourb OF, Al-Tuweiqc GM, Alzubi MA, Alkadhi KA. Adverse effect of combination of chronic psychosocial stress and high fat diet on hippocampusdependent memory in rats. Behav Brain Res 2009; 204: 117- 123.
2. Lim S, Won H, Kim Y, Jang M, Jyothi KR, Kim Y, Dandona P, Ha J, Kim SS. Antioxidant enzymes induced by repeated intake of excess energy in the form of high-fat, high-carbohydrate meals are not sufficient to block oxidative stress in healthy lean individuals. Br J Nutr 2011; 106: 1544-1551.
3. Rani V, Deep G, Singh RK, Palle K, Yadav UC. Oxidative stress and metabolic disorders: pathogenesis and therapeutic strategies. Life Sci 2016;148: 183-193.
4. Charradi K, Elkahoui S, Limam F, Aouani E. High-fat diet induced an oxidative stress in white adipose tissue and disturbed plasma transition metals in rat: prevention by grape seed and skin extract. J Physiol Sci 2013; 63: 445-455.
5. Sahin K, Onderci M, Tuzcu M, Ustundag B, Cikim G, Ozercan IH, Sriramoju V, Juturu V, Komorowski JR. Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat. Metabolism 2007; 56: 1233-1240.
6. Dogukan A, Tuzcu M, Juturu V, Cikim G, Ozercan IH, Komorowski J, Sahin K. Effects of chromium histidinate on renal function, oxidative stress, and heat-shock proteins in fatfed and streptozotocin-treated rats. J Ren Nutr 2010; 20: 112- 120.
7. Lindqvist A, Mohapel P, Bouter B, Frielingsdorf H, Pizzo D, Brundin P, Erlanson-Albertsson C. High-fat diet impairs hippocampal neurogenesis in male rats. Eur J Neurol 2006; 13: 1385-1388.
8. Alsaif MA, Duwaihy MMS. Influence of dietary fat quantity and composition on glucose tolerance and insulin sensitivity in rats. Nutr Res 2004; 24: 417-425.
9. Kim J, Kim J, Kwon YH. Effects of disturbed liver growth and oxidative stress of high-fat diet-fed dams on cholesterol metabolism in offspring mice. Nutr Res Pract 2016; 10: 386- 392.
10. Costello RB, Dwyer JT, Bailey RL. Chromium supplements for glycemic control in type 2 diabetes: limited evidence of effectiveness. Nutr Rev 2016; 74: 455-468.
11. Kim DS, Kim TW, Kung JS. Chromium supplementation improves insulin sensitivity in Goto-Kakizaki diabetic rats. J Trace Elem Med Biol 2004; 17: 243-247.
12. Chen S, Li KW. Comparison of molecular species of various transphosphatidylated phosphatidylserine (PS) with bovine cortex PS by mass spectrometry. Chem Phys Lipids 2008; 152: 46-56.
13. De Tonnac A, Labussière E, Vincent A, Mourot J. Effect of α-linolenic acid and DHA intake on lipogenesis and gene expression involved in fatty acid metabolism in growingfinishing pigs. Br J Nutr 2016; 116: 7-18.
14. Pifferi F, Roux F, Langelier B, Alessandri JM, Vancassel S, Jouin M, Lavialle M, Guesnet P. (n-3) polyunsaturated fatty acid deficiency reduces the expression of both isoforms of the brain glucose transporter GLUT1 in rats. J Nutr 2005; 135: 2241- 2246.
15. Suchy J, Chan A, Shea TB. Dietary supplementation with a combination of α-lipoic acid, acetyl-L-carnitine, glycerophosphocoline, docosahexaenoic acid, and phosphatidylserine reduces oxidative damage to murine brain and improves cognitive performance. Nutr Res 2009; 29: 70-74.
16. Bhasker TV, Gowda NK, Mondal S, Krishnamoorthy P, Pal DT, Mor A, Bhat SK, Pattanaik AK. Boron influences immune and antioxidant responses by modulating hepatic superoxide dismutase activity under calcium deficit abiotic stress in Wistar rats. J Trace Elem Med Biol 2016; 36: 73-79.
17. Eren M, Kocaoglu-Güçlü B, Uyanik F, Karabulut N. The effects of dietary boron supplementation on performance, carcass composition and serum lipids in Japanese quails. J Anim Vet Adv 2006; 5: 1105-1108.
18. Nielsen FH, Penland JG. Boron deprivation alters rat behaviour and brain mineral composition differently when fish oil instead of safflower oil is the diet fat source. Nutr Neurosci 2006; 9: 105- 112.
19. Nielsen FH. The emergence of boron as nutritionally important throughout the life cycle. Nutrition 2000; 16: 7-8.
20. Matsuda M, De Fronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin camp. Diabetes Care 1999; 22: 1462-1470.
21. Dogukan A, Sahin N, Tuzcu M, Juturu V, Orhan C, Onderci M, Komorowski J, Sahin K. The effects of chromium histidinate on mineral status of serum and tissue in fat-fed and streptozotocintreated type II diabetic rats. Biol Trace Elem Res 2009; 131: 124- 132.
22. Gencoglu H, Tuzcu M, Hayirli A, Sahin K. Protective effects of resveratrol against streptozotocin-induced diabetes in rats by modulation of visfatin/sirtuin-1 pathway and glucose transporters. Int J Food Sci Nutr 2015; 66: 314-320.
23. Havrankova J, Schmechelt D, Roth J, Brownstein M. Identification of insulin in rat brain. Neurobiology 1978; 75: 5737-5741.
24. Morris RG, Garrud P, Rawlins JN. Place navigation impaired in rats with hippocampal lesions. Nature 1982; 297: 681-683.
25. Baydas G, Yasar A, Tuzcu M. Comparison of the impact of melatonin on chronic ethanol induced learning and memory impairment between young and aged rats. J Pineal Res 2005; 39: 346-352.
26. Kamal A, Biessels GJ, Duis SE. Learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: interaction of diabetes and ageing. Diabetologia 2000; 43: 500-506.
27. Chung YM, Lee JH, Kim DY, Hwang SH, Hong YH, Kim SB, Lee SJ, Park CH. Dietary D-psicose reduced visceral fat mass in highfat diet-induced obese rats. J Food Sci 2012; 77: 53-58.
28. Sahin K, Tuzcu M, Orhan C, Agca CA, Sahin N, Guvenc M, Krejpcio Z, Staniek H, Hayirli A. The effects of chromium complex and level on glucose metabolism and memory acquisition in rats fed high-fat diet. Biol Trace Elem Res 2011; 143: 1018-1030.
29. Lomba A, Martínez JA, García Díaz DF, Paternain L, Marti A, Campión J, Milagro FI. Weight gain induced by an isocaloric pair-fed high fat diet: a nutriepigenetic study on FASN and NDUFB6 gene promoters. Mol Genet Metab 2010; 101: 273-278.
30. Oosterveer MH, van Dijk TH, Tietge UJ, Boer T, Havinga R, Stellaard F, Groen AK, Kuipers F, Reijngoud DJ. High fat feeding induces hepatic fatty acid elongation in mice. PLoS One 2009; 4: e6066.
31. Pattar GR, Tackett L, Liu P, Elmendorf JS. Chromium picolinate positively influences the glucose transporter system via affecting cholesterol homeostasis in adipocytes cultured under hyperglycemic diabetic conditions. Mutation Res 2006; 610: 93- 100.
32. Chen H, Liu LJ, Zhu JJ, Xu B, Li R. Effect of soybean oligosaccharides on blood, glucose levels and antioxidant enzyme activity in high fat rats. Food Chem 2010; 119: 1633- 1638.
33. Krzysik M, Grajeta H, Prescha A, Weber R. Effect of cellulose, pectin and chromium(III) on lipid and carbohydrate metabolism in rats. J Trace Elem Med Biol 2011; 25: 97-102.
34. Cefalu WT, Wang ZQ, Zhang XH, Baldor LC, Russell JC. Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats. J Nutr 2002; 132: 1107-1114.
35. Krol E, Krejpcio Z. Evaluation of anti-diabetic potential of chromium(III) propionate complex in high-fat diet fed and STZ injected rats. Food Chem Toxicol 2011; 49: 3217-3223.
36. Padmavathi IJ, Rao KR, Venu L, Ganeshan M, Kumar KA, Rao CN, Harishankar N, Ismail A, Raghunath M. Chronic maternal dietary chromium restriction modulates visceral adiposity: probable underlying mechanisms. Diabetes 2010; 59: 98-104.
37. Engstrom K, Saldeen AS, Yang B, Mehta JL, Saldeen T. Effect of fish oils containing different amounts of EPA, DHA, and antioxidants on plasma and brain fatty acids and brain nitric oxide synthase activity in rats. Ups J Med Sci 2009; 114: 206- 213.
38. Starks MA, Starks SL, Kingsley M, Purpura M, Jäger R. The effects of phosphatidylserine on endocrine response to moderate intensity exercise. J Int Soc Sports Nutr 2008; 5: 11.
39. Naghii MR, Darvishi P, Ebrahimpour Y, Ghanizadeh G, Mofid M, Hedayati M, Asgari AR. Effect of combination therapy of fatty acids, calcium, vitamin D and boron with regular physical activity on cardiovascular risk factors in rat. J Oleo Sci 2012; 61: 103-111.
40. Bakken NA, Hunt CD. Dietary boron decreases peak pancreatic in situ insulin release in chicks and plasma insulin concentrations in rats regardless of vitamin D or magnesium status. J Nutr 2003; 133: 3577-3583.
41. Devirian TA, Volpe SL. The physiological effects of dietary boron. Crit Rev Food Sci Nutr 2003; 43: 219-231.
42. Stearns DM, Belbruno JJ, Wetterhahn KE. A prediction of chromium (III) accumulation in humans from chromium dietary supplements. FASEB 1995; 9: 16501657.
43. Mita Y, Ishihara K, Fukuchi Y, Fukuya Y, Yasumoto K. Supplementation with chromium picolinate recovers renal Cr concentration and improves carbohydrate metabolism and renal function in type 2 diabetic mice. Biol Trace Elem Res 2005; 105: 229-248.
44. Chen WY, Mao FC, Liu CH, Kuan YH, Lai NW, Wu CC, Chen CJ. Chromium supplementation improved post-stroke brain infarction and hyperglycemia. Metab Brain Dis 2016; 31: 289- 297.
45. Chen WY, Chen CJ, Liu CH, Mao FC. Chromium supplementation enhances insulin signalling in skeletal muscle of obese KK/HlJ diabetic mice. Diabetes Obes Metab 2009; 11: 293-303.
46. Preuss HG, Echard B, Perricone NV, Bagchic D, Yasmin T, Stohs SJ. Comparing metabolic effects of six different commercial trivalent chromium compounds. J Inorg Biochem 2008; 102: 1986-1990.
47. Li W, Shi YH, Yang R, Cui J, Xiao Y, Wang B, Le GW. Effect of somatostatin analog on high-fat diet-induced metabolic syndrome: involvement of reactive oxygen species. Peptides 2010; 31: 625-629.
48. Wang J, Cao Y, Wang C, Sun B. Wheat bran xylooligosaccharides improve blood lipid metabolism and antioxidant status in rats fed a high-fat diet. Carb Poly 2011; 86: 1192-1197.
49. Goyal R, Singhai M, Faizy AF. Glutathione peroxidase activity in obese and nonobese diabetic patients and role of hyperglycemia in oxidative stress. J Midlife Health 2011; 2: 72- 76.
50. Bondia Pons I, Ryan L, Martinez JA. Oxidative stress and inflammation interactions in human obesity. J Physiol Biochem 2012; 68: 701-711.
51. Lupachyk S, Watcho P, Hasanova N, Julius U, Obrosova IG. Triglyceride, nonesterified fatty acids, and prediabetic neuropathy: role for oxidative-nitrosative stress. Free Radic Biol Med 2012; 52: 1255-1263.
52. Pan HC, Kao TK, Ou YC, Yang DY, Yen YJ, Wang CC, Chuang YH, Liao SL, Raung SL, Wu CW et al. Protective effect of docosahexaenoic acid against brain injury in ischemic rats. J Nutr Biochem 2009; 20: 715-725.
53. Le Floch N, Otten W, Merlot E. Tryptophan metabolism, from nutrition to potential therapeutic applications. Amino Acids 2011; 41: 1195-1205.
54. Meguid MM, Fetissov SO, Varma M, Sato T, Zhang L, Laviano A, Rossi-Fanelli F. Hypothalamic dopamine and serotonin in the regulation of food intake. Nutr 2000; 16: 843-857.
55. Kirac D, Ozden I, Yildirim A, Genç E. Effect of high-fat intake on motor activity, homovanillic acid and 5-hydroxyindoleacetic acid levels in striatum and cortex of rats exposed to stress. Nutr Neurosci 2009; 12: 89-94.
56. Attenburrow MJ, Odontiadis J, Murray BJ, Cowen PJ, Franklin M. Chromium treatment decreases the sensitivity of 5-HT2A receptors. Psychopharmacology (Berl) 2002; 159: 432-436.
57. Khanam R, Pillai KK. Effect of chronic chromium picolinate in animal models of anxiety and memory. Fundam Clin Pharmacol 2007; 21: 531-534.
58. Dubey VK, Ansari F, Vohora D, Khanam R. Possible involvement of corticosterone and serotonin in antidepressant and antianxiety effects of chromium picolinate in chronic unpredictable mild stress induced depression and anxiety in rats. J Trace Elem Med Biol 2015; 29: 222-226.
59. Horrocks LA, Yeo YK. Health benefits of docosahexaenoic acid (DHA). Pharmacol Res 1999; 40: 211-225.
60. Kidd PM. A review of nutrients and botanicals in the integrative management of cognitive dysfunction. Altern Med Rev 1999; 4: 144-161.
61. Strachan MW, Deary IJ, Ewing FM, Frier BM. Cognitive function and information processing in type 2 diabetes. Diabetic Med 2001; 18: 803-810.
62. Strachan MW, Deary IJ, Ewing FM, Frier BM. Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care 1997; 20: 438-445.
63. Biessels GJ, Kamal A, Urban IJ, Sprujit BM, Erkelens DW, Gispen WH. Water maze learning and hippocampal synaptic plasticity in streptozotocin diabetic rats: effects of insulin treatment. Brain Res 1998; 800: 125-135.
64. Chaung HC, Chang CD, Chen PH, Chang CJ, Liu SH, Chen CC. Docosahexaenoic acid and phosphatidylserine improves the antioxidant activities in vitro and in vivo and cognitive functions of the developing brain. Food Chem 2013; 138: 342- 347.
65. Liu SH, Chang CD, Chen PH, Su JR, Chen CC, Chaung HC. Docosahexaenoic acid and phosphatidylserine supplementations improve antioxidant activities and cognitive functions of the developing brain on pentylenetetrazolinduced seizure model. Brain Res 2012; 1451: 19-26.
66. Chung WL, Chen JJ, Su HM. Fish oil supplementation of control and (n-3) fatty acid-deficient male rats enhances reference and working memory performance and increases brain regional docosahexaenoic acid levels. J Nutr 2008; 138: 1165-1171.
67. Chang CY, Kuan YH, Li JR, Chen WY, Ou YC, Pan HC, Liao SL, Raung SL, Chang CJ, Chen CJ. Docosahexaenoic acid reduces cellular inflammatory response following permanent focal cerebral ischemia in rats. J Nutr Biochem 2013; 24: 2127- 2137.
68. Hegsted M, Keenan MJ, Siver F, Wozniak P. Effect of boron on vitamin D deficient rats. Biol Trace Elem Res 1991; 28: 243- 255.
69. Penland JG. The importance of boron nutrition for brain and psychological function. Biol Trace Elem Res 1998; 66: 299-317.